Patients & Healthcare Professionals News Career
Mobile Button Search>
Pre-IND
Phase I
Phase II
Phase III
Registration
Marketed

Hematology

P1101
PV (EU)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
PV (US, JP, CN, KR, TW)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
ET (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
CML (EU)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
PMF (US)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Infectious Disease

P1101
HCV-G2 (TW, KR, CN)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Infectious Disease

P1101
HBV e+ (TW, KR, CN, VN, TH)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Infectious Disease

P1101
HBV e+ add on (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Oncology

Oraxol
Breast (TW, SG, VN)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Oncology

Oraxol+Ramucirumab
Gastric (TW, SG, VN)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Dermatology

KX01
Psoriasis (TW, SIN, CN, HK, MC, MY)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA